Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Tables Plugin

Biotech Emyria (ASX:EMD) says it is well positioned to accelerate patient access to MDMA-assisted therapies following the recent TGA regulation changes down-scheduling MDMA and psilocybin to Schedule 8 medicines from July 1st, 2023.

A similar rescheduling of medicinal cannabis from Schedule 9 to Schedule 8 occurred in 2016.

Cancer fighter Imagion Biosystems (ASX:IBX) says an independent blinded review by a panel of expert breast cancer radiologists has corroborated the company’s previously reported positive findings.

The panel confirmed cancer detection can be achieved when using IBX’s MagSense imaging agent with MRI which “has significant implications for the company”.

And a maiden drill hole at Kuniko’s (ASX:KNI) Ertelien Ni-Cu-Co deposit n Norway has “significant mineralised intervals with massive sulphides of greater than 90%”. Assays are pending.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

WordPress Tables Plugin